Novo Nordisk (NVO.N) filed for a preliminary injunction in U.S. District Court
in New Jersey seeking an immediate halt to Eli Lilly's (LLY.N) GLP-1 advertising
campaign, which Novo Nordisk says is misleading, pending resolution of the
litigation.
2026-07-24
Novo Nordisk (NVO.N) filed for a preliminary injunction in U.S. District Court
in New Jersey seeking an immediate halt to Eli Lilly's (LLY.N) GLP-1 advertising
campaign, which Novo Nordisk says is misleading, pending resolution of the
litigation.